The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers
AbstractThe aim of this study was to prepare and examine polymer/oxide xerogels with metronidazole (MT) as delivery systems for the local application of a drug to a bone. The nanoporous SiO2-CaO and PDMS-modified SiO2-CaO xerogel materials with different amounts of the polymer, polydimethylsiloxane (PDMS), were prepared by the sol-gel method. Characterization assays comprised the analysis of the composite materials by using Fourier transform infrared spectroscopy (FTIR), determining the specific surface area of solids (BET), using X-ray powder diffraction (XRD) and scanning electron microscope (SEM) techniques, and further monitoring in the ultraviolet and visible light regions (UV-Vis) of the in vitro release of the drug (metronidazole) over time. According to these results, the bioactive character and chemical stability of PDMS-modified silica xerogels have been proven. The release of MT from xerogels was strongly correlated with the composition of the matrix. In comparison with the pure oxide matrix, PDMS-modified matrices accelerated the release of the drug through its bigger pores, and additionally, on account of weaker interactions with the drug. The obtained results for the xerogel composites suggest that the metronidazole-loaded xerogels could be promising candidates for formulations in local delivery systems particularly to bone.
Share & Cite This Article
CZARNOBAJ, K. The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers. Sci. Pharm. 2015, 83, 519-533.
CZARNOBAJ K. The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers. Scientia Pharmaceutica. 2015; 83(3):519-533.Chicago/Turabian Style
CZARNOBAJ, Katarzyna. 2015. "The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers." Sci. Pharm. 83, no. 3: 519-533.